scholarly journals Heparin Anticoagulation during Cardiopulmonary Bypass for Thoracoabdominal Aorta Replacement in a Patient with a History of Heparin-Induced Thrombocytopenia

2010 ◽  
Vol 39 (3) ◽  
pp. 144-147
Author(s):  
Masanao Ohba ◽  
Hirokazu Murayama ◽  
Hiroyuki Kito ◽  
Kozo Matsuo ◽  
Naoki Hayashida ◽  
...  
2003 ◽  
Vol 96 (2) ◽  
pp. 344-350 ◽  
Author(s):  
Gregory A. Nuttall ◽  
William C. Oliver ◽  
Paula J. Santrach ◽  
Robert D. McBane ◽  
Daniel B. Erpelding ◽  
...  

2018 ◽  
Vol 23 (2) ◽  
pp. 256-260 ◽  
Author(s):  
Warsame Ibrahim ◽  
Hunter Nakia ◽  
Miller Stephen ◽  
Spiess Bruce ◽  
Whitson Bryan ◽  
...  

Anticoagulation for cardiopulmonary bypass (CPB) is required to prevent acute disseminated intravascular coagulation and clot formation within the bypass circuit. Unfractionated heparin is the standard anticoagulant for CPB due to its many advantages and long history of successful use. However, heparin has the unique drawback of triggering Heparin-PF4 (PF4) antibodies potentially leading to heparin-induced thrombocytopenia (HIT). We have limited data regarding reformation of antibodies if a patient has had a prior (remote) antibody production or full HIT. Patients with antiphospholipid antibodies undergoing CPB with unfractionated heparin have a high complication rate, even in the absence of HIT. Antiphospholipid antibodies have a multifaceted, cumulatively inhibitory effect on the normal anticoagulation armamentarium in vivo. Even more concerning is the possibility that antiphospholipid syndrome and HIT may be synergistic. We report a patient with risk factors for both thromboembolic (remote history of HIT and antiphospholipid syndrome) and hemorrhagic complications who underwent an aortic valve replacement and coronary artery bypass grafting on CPB using bivalirudin. We discuss the complex decision making regarding anticoagulant for CPB, particularly with regard to American College of Chest Physicians guidelines.


2001 ◽  
Vol 71 (3) ◽  
pp. 1041-1042 ◽  
Author(s):  
Sixten Selleng ◽  
Norbert Lubenow ◽  
Hans-Georg Wollert ◽  
Bernd Müllejans ◽  
Andreas Greinacher

2003 ◽  
Vol 96 (2) ◽  
pp. 344-350 ◽  
Author(s):  
Gregory A. Nuttall ◽  
William C. Oliver ◽  
Paula J. Santrach ◽  
Robert D. McBane ◽  
Daniel B. Erpelding ◽  
...  

1994 ◽  
Vol 72 (05) ◽  
pp. 783-784 ◽  
Author(s):  
Y Cadroy ◽  
J Amiral ◽  
H Raynaud ◽  
P Brunel ◽  
A Mazaleyrat ◽  
...  

2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
B Casini ◽  
B Tuvo ◽  
M Totaro ◽  
A Baggiani ◽  
G Privitera

Abstract Background Disseminated M. chimaera infections among patients who underwent open-chest surgery with cardiopulmonary bypass have been associated with the contamination of heater-cooler devices (HCDs). The Tuscany region in the Decree 3822/2019 issued recommendations for the surveillance and control of M. chimaera infections. Methods In three Tuscan cardiac surgery centers, the case finding was carried out through evaluation and testing of patients with a history of HCD exposure (past 6 years) was performed. Water and aerosol samples were analyzed from each HCDs to determine the microbiological parameters required by the Directive 98/83/CE and to assess the presence of non-tuberculous mycobacteria (NTMs), according to the regional protocol. Results M. chimaera infection was not found in any patient and all clinical specimens tested negative. 22 HCDs were sampled (n.12 LivaNova, n.1 Terumo and n.9 Maquet) for a total of 114 samples (45, 8, 2 and 59 respectively). All the microbiological parameters were compliant, excepted for total microbial count at 36 °C that exceeded 100 CFU/ml in 50% (57/114) of samples and for the presence of P.aeruginosa in 10% (12/114). NTMs were detected in 16% (18/114) of HCDs: M. chimaera was identified in 11% (13/114) of samples and in 4% (5/114) M. gordonae. All aerosol samples were negative for NTMs, but in the HCDs Maquet, B.cereus were detected in 7% (4/59) of the samples, K.oxytoca in 2% (1/59), B.ursincola in 2% (1/59) and S. paucimobilis in 3% (2/59). Only S. paucimobilis was isolated also in the same HCD water sample. Conclusions The implementation of maintenance and disinfection procedures of HCDs was able to reduce the risk of contamination and aerosolization by NTMs but not of other microorganisms. Key messages Further strategies should be put in place for the cases finding. Moreover, reliable decontamination and identification of agents that can disrupt biofilms and increase chlorine susceptibility of mycobacteria are required.


Sign in / Sign up

Export Citation Format

Share Document